Company Announcements

RNS Number : 4813D
Elixirr International PLC
20 October 2022
 

ELIXIRR INTERNATIONAL PLC

("Elixirr", the "Company" or the "Group")

PCA Dealing

Elixirr International plc (AIM: ELIX), an established, global award-winning challenger consultancy, announces that on 19 October 2022, the Company was notified that on 18 October 2022, Zhanna Bichler, the wife of Brandon Bichler, Partner and a PDMR of the Company, acquired a total of 9,127 ordinary shares of 0.005p each in the Company ("Ordinary Shares") at a price of 550 pence per Ordinary Share.

Following the purchase, Brandon Bichler's beneficial holding (including those held by his wife) is 712,191 Ordinary Shares representing 1.54 per cent of the issued share capital of the Company.

 

For further Information please contact:

Elixirr International plc

 

Stephen Newton, CEO

 

Graham Busby, CFO

 

 

 

 

Public and Investor Relations contacts:

Caroline Pitt

 

 

finnCap Ltd (Nominated Adviser & Sole Broker)

 

Christopher Raggett (Corporate Finance)

 

Alice Lane / Sunila De Silva (ECM)

 

 

investor-relations@elixirr.com

 

 

 

 

                                                            

+44 (0)20 7220 0500

 

 


About Elixirr International plc

Elixirr is an established global award-winning management consultancy, challenging the larger consultancies by delivering innovative and bespoke solutions to a repeat, globally-recognised client base.

Elixirr was founded in 2009, by Stephen Newton, Graham Busby, Ian Ferguson, Andy Curtis and Mark Goodyear, experienced business advisors who identified a market opportunity to provide bespoke, personal services as a 'challenger' to the traditional consultancy businesses in the market. Elixirr guides its clients to overcome challenges such as: future-proofing against technological disruption; development and roll-out of new propositions, products and services; incubating new businesses; navigating a more complex and multinational regulatory environment; and project management and implementation of major change programmes.

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the company's obligations under Article 17 of MAR.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Zhanna Bichler

2.     

Reason for the Notification

a)

Position/status

PCA to Partner and PDMR, Brandon Bichler

b)

Initial notification/Amendment

Initial Notification

3.  

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Elixirr International plc

b)

LEI

213800MKY7OHMVAKW681

4.  

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 0.005p each ("Ordinary Shares")

Identification code

GB00BLPHTX84

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

550p

9,127

d)

Aggregated information:

 

9,127 shares at 550p

 

e)

Date of the transaction

18 October 2022

f)

Place of the transaction

London Stock Exchange, AIM market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEANENFDPAFFA